Process View
The change in morphology and behavior of a eosinophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "eosinophil activation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.996 | Human | |
| TFF1 | trefoil factor 1 | 0.964 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.941 | ||
| IL8 | interleukin 8 | 0.894 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.741 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.695 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.686 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.669 | Human | |
| IL1B | interleukin 1, beta | 0.607 | ||
| IDE | insulin-degrading enzyme | 0.589 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.586 | ||
| ANKRD27 | ankyrin repeat domain 27 (VPS9 domain) | 0.506 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.496 | ||
| IL2RB | interleukin 2 receptor, beta | 0.454 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.445 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.429 | Human | |
| IFNG | interferon, gamma | 0.407 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.376 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.370 | Human | |
| CCL3 | chemokine (C-C motif) ligand 3 | 0.360 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.340 | Human | |
| IL10 | interleukin 10 | 0.330 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.327 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.259 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.241 | ||
| FPR3 | formyl peptide receptor 3 | 0.232 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.221 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.193 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.191 | ||
| NKG7 | natural killer cell group 7 sequence | 0.190 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.187 | Human | |
| AGFG1 | ArfGAP with FG repeats 1 | 0.173 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.167 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.163 | ||
| CAV2 | caveolin 2 | 0.162 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.157 | ||
| GNLY | granulysin | 0.156 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.151 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.148 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.148 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.128 | Human | |
| IL18RAP | interleukin 18 receptor accessory protein | 0.127 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.114 | ||
| TNF | tumor necrosis factor | 0.112 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.109 | ||
| INADL | InaD-like (Drosophila) | 0.105 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.103 | ||
| SELE | selectin E | 0.098 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.098 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.097 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.095 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.095 | ||
| UBD | ubiquitin D | 0.088 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.085 | ||
| GPR171 | G protein-coupled receptor 171 | 0.081 | ||
| CD83 | CD83 molecule | 0.078 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.077 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.073 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.072 | ||
| RUNX3 | runt-related transcription factor 3 | 0.072 | ||
| SLAMF7 | SLAM family member 7 | 0.071 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.071 | ||
| CH25H | cholesterol 25-hydroxylase | 0.067 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.066 | ||
| CD80 | CD80 molecule | 0.063 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.062 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.061 | ||
| DARC | Duffy blood group, chemokine receptor | 0.057 | ||
| HK3 | hexokinase 3 (white cell) | 0.057 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.056 | ||
| CD48 | CD48 molecule | 0.055 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.054 | ||
| CD69 | CD69 molecule | 0.052 | ||
| IL32 | interleukin 32 | 0.052 | ||
| ARRB1 | arrestin, beta 1 | 0.050 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.050 | Human | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.049 | ||
| IL21R | interleukin 21 receptor | 0.048 | ||
| IRF8 | interferon regulatory factor 8 | 0.048 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.048 | ||
| CD160 | CD160 molecule | 0.045 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.045 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.044 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.043 | Human | |
| XCL2 | chemokine (C motif) ligand 2 | 0.042 | Human | |
| C5AR1 | complement component 5a receptor 1 | 0.042 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.042 | ||
| CTSW | cathepsin W | 0.041 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.040 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.040 | ||
| IL7R | interleukin 7 receptor | 0.040 | ||
| GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.040 | ||
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.039 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.039 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.038 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.037 | Human | |
| DOK2 | docking protein 2, 56kDa | 0.037 | ||
| SLAMF8 | SLAM family member 8 | 0.036 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.036 | ||
| CD86 | CD86 molecule | 0.035 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.035 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.034 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.034 | ||
| SDS | serine dehydratase | 0.033 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.033 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.033 | ||
| XCL1 | chemokine (C motif) ligand 1 | 0.032 | Human | |
| IL13 | interleukin 13 | 0.032 | ||
| TFEC | transcription factor EC | 0.031 | ||
| MSC | musculin | 0.030 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.030 | ||
| ICOS | inducible T-cell co-stimulator | 0.030 | ||
| CD1C | CD1c molecule | 0.030 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.030 | ||
| CD8A | CD8a molecule | 0.029 | ||
| CST7 | cystatin F (leukocystatin) | 0.029 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.029 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.028 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.028 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.028 | ||
| IL1A | interleukin 1, alpha | 0.028 | ||
| PVRIG | poliovirus receptor related immunoglobulin domain containing | 0.027 | ||
| CD163 | CD163 molecule | 0.027 | ||
| PLA2G2D | phospholipase A2, group IID | 0.027 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.026 | ||
| CD2 | CD2 molecule | 0.026 | ||
| LY86 | lymphocyte antigen 86 | 0.026 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.025 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.025 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.025 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.025 | ||
| C2 | complement component 2 | 0.024 | ||
| P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 0.024 | Human | |
| PROCR | protein C receptor, endothelial | 0.024 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.024 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.024 | ||
| CD84 | CD84 molecule | 0.024 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.024 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.023 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.023 | ||
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.023 | ||
| CD1B | CD1b molecule | 0.023 | ||
| PDCD1LG2 | programmed cell death 1 ligand 2 | 0.023 | ||
| INHBA | inhibin, beta A | 0.023 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.023 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.023 | ||
| KLRF1 | killer cell lectin-like receptor subfamily F, member 1 | 0.022 | ||
| GPR84 | G protein-coupled receptor 84 | 0.022 | ||
| ITK | IL2-inducible T-cell kinase | 0.022 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.022 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.022 | ||
| BIN2 | bridging integrator 2 | 0.021 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.021 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.021 | ||
| CD300C | CD300c molecule | 0.021 | Human | |
| DMBT1 | deleted in malignant brain tumors 1 | 0.021 | ||
| GPR35 | G protein-coupled receptor 35 | 0.020 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.020 | ||
| TARP | TCR gamma alternate reading frame protein | 0.020 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.020 | ||
| APOC1 | apolipoprotein C-I | 0.020 | ||
| CCBP2 | chemokine binding protein 2 | 0.020 | ||
| IRF4 | interferon regulatory factor 4 | 0.020 | ||
| CD209 | CD209 molecule | 0.020 | ||
| IL11 | interleukin 11 | 0.020 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.020 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.020 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.020 | ||
| AQP9 | aquaporin 9 | 0.019 | ||
| CD300LB | CD300 molecule-like family member b | 0.019 | Human | |
| SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.019 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.019 | ||
| SLC25A46 | solute carrier family 25, member 46 | 0.019 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.019 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.019 | ||
| ADORA3 | adenosine A3 receptor | 0.019 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.018 | ||
| TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.018 | ||
| ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | 0.018 | ||
| TM7SF4 | transmembrane 7 superfamily member 4 | 0.018 | ||
| IGL@ | immunoglobulin lambda locus | 0.018 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.018 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.018 | ||
| TBX21 | T-box 21 | 0.018 | ||
| MOSPD1 | motile sperm domain containing 1 | 0.018 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.018 | ||
| IL19 | interleukin 19 | 0.018 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.017 | ||
| MUC5B | mucin 5B, oligomeric mucus/gel-forming | 0.017 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.017 | ||
| OSMR | oncostatin M receptor | 0.017 | ||
| IL4I1 | interleukin 4 induced 1 | 0.017 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.017 | ||
| APOBR | apolipoprotein B receptor | 0.017 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.017 | ||
| XCR1 | chemokine (C motif) receptor 1 | 0.017 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.017 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.017 | Human | |
| LTF | lactotransferrin | 0.017 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.017 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.016 | ||
| IL18BP | interleukin 18 binding protein | 0.016 | ||
| SCARF1 | scavenger receptor class F, member 1 | 0.016 | ||
| LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 | 0.016 | ||
| CCL24 | chemokine (C-C motif) ligand 24 | 0.016 | Human | |
| TPSB2 | tryptase beta 2 (gene/pseudogene) | 0.016 | ||
| IL1F5 | interleukin 1 family, member 5 (delta) | 0.016 | ||
| DPT | dermatopontin | 0.016 | ||
| CD300A | CD300a molecule | 0.015 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.015 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.015 | ||
| NNMT | nicotinamide N-methyltransferase | 0.015 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.015 | ||
| GPR109B | G protein-coupled receptor 109B | 0.015 | ||
| CHI3L2 | chitinase 3-like 2 | 0.015 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.015 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.015 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.015 | ||
| SELL | selectin L | 0.015 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.015 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.015 | ||
| SIGLEC12 | sialic acid binding Ig-like lectin 12 | 0.015 | ||
| CX3CR1 | chemokine (C-X3-C motif) receptor 1 | 0.015 | ||
| OSM | oncostatin M | 0.015 | ||
| GPR183 | G protein-coupled receptor 183 | 0.014 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.014 | ||
| RASGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | 0.014 | ||
| PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.014 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.014 | ||
| IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 0.014 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.014 | ||
| KIR3DL1 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 | 0.014 | ||
| UBE4A | ubiquitination factor E4A (UFD2 homolog, yeast) | 0.014 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.014 | ||
| ALPI | alkaline phosphatase, intestinal | 0.014 | ||
| CD101 | CD101 molecule | 0.014 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.014 | ||
| ABI3 | ABI family, member 3 | 0.014 | ||
| BDKRB1 | bradykinin receptor B1 | 0.014 | ||
| TRAT1 | T cell receptor associated transmembrane adaptor 1 | 0.014 | ||
| EMILIN2 | elastin microfibril interfacer 2 | 0.014 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.014 | ||
| NFAM1 | NFAT activating protein with ITAM motif 1 | 0.014 | ||
| TNIP3 | TNFAIP3 interacting protein 3 | 0.014 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.014 | ||
| CST4 | cystatin S | 0.014 | ||
| MMP19 | matrix metallopeptidase 19 | 0.014 | ||
| SELPLG | selectin P ligand | 0.013 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.013 | ||
| PDPN | podoplanin | 0.013 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.013 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.013 | ||
| PGRMC1 | progesterone receptor membrane component 1 | 0.013 | ||
| CLEC4A | C-type lectin domain family 4, member A | 0.013 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.013 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.013 | ||
| STX11 | syntaxin 11 | 0.013 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.013 | ||
| PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.013 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.013 | ||
| GPR65 | G protein-coupled receptor 65 | 0.013 | ||
| ABP1 | amiloride binding protein 1 (amine oxidase (copper-containing)) | 0.013 | ||
| CETP | cholesteryl ester transfer protein, plasma | 0.013 | ||
| ICOSLG | inducible T-cell co-stimulator ligand | 0.013 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.013 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.013 | ||
| SAA2 | serum amyloid A2 | 0.013 | ||
| IL9 | interleukin 9 | 0.013 | ||
| CLC | Charcot-Leyden crystal protein | 0.013 | ||
| PTEN | phosphatase and tensin homolog | 0.013 | ||
| PLA1A | phospholipase A1 member A | 0.012 | ||
| HS3ST1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 0.012 | ||
| KIFC3 | kinesin family member C3 | 0.012 | ||
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 0.012 | ||
| MUC4 | mucin 4, cell surface associated | 0.012 | ||
| TXNRD1 | thioredoxin reductase 1 | 0.012 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.012 | ||
| TREM2 | triggering receptor expressed on myeloid cells 2 | 0.012 | ||
| FUT3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | 0.012 | ||
| CST2 | cystatin SA | 0.012 | ||
| FAM20A | family with sequence similarity 20, member A | 0.012 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.012 | ||
| SDPR | serum deprivation response | 0.012 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.012 | ||
| PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.012 | ||
| CCNDBP1 | cyclin D-type binding-protein 1 | 0.012 | ||
| MYO1A | myosin IA | 0.012 | ||
| MOXD1 | monooxygenase, DBH-like 1 | 0.012 | ||
| GPBAR1 | G protein-coupled bile acid receptor 1 | 0.012 | ||
| DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 0.012 | ||
| FFAR2 | free fatty acid receptor 2 | 0.012 | ||
| HCST | hematopoietic cell signal transducer | 0.012 | ||
| TAGAP | T-cell activation RhoGTPase activating protein | 0.012 | ||
| KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 | 0.012 | ||
| NCOA4 | nuclear receptor coactivator 4 | 0.012 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.012 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.012 | ||
| CRTAM | cytotoxic and regulatory T cell molecule | 0.012 | ||
| GFRA4 | GDNF family receptor alpha 4 | 0.012 | ||
| TNFAIP8L2 | tumor necrosis factor, alpha-induced protein 8-like 2 | 0.012 | ||
| GGT5 | gamma-glutamyltransferase 5 | 0.012 | ||
| AMPD1 | adenosine monophosphate deaminase 1 | 0.012 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.012 | ||
| CD33 | CD33 molecule | 0.012 | ||
| TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 | 0.012 | ||
| OPTC | opticin | 0.012 | ||
| CETN2 | centrin, EF-hand protein, 2 | 0.012 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.012 | ||
| CD40LG | CD40 ligand | 0.012 | ||
| IL24 | interleukin 24 | 0.012 | ||
| GPR97 | G protein-coupled receptor 97 | 0.012 | ||
| TIFAB | TRAF-interacting protein with forkhead-associated domain, family member B | 0.012 | ||
| CD1A | CD1a molecule | 0.012 | ||
| GJA5 | gap junction protein, alpha 5, 40kDa | 0.011 | ||
| CD72 | CD72 molecule | 0.011 | ||
| SMAP1 | small ArfGAP 1 | 0.011 | ||
| PITPNM3 | PITPNM family member 3 | 0.011 | ||
| SNX3 | sorting nexin 3 | 0.011 | ||
| KLRC3 | killer cell lectin-like receptor subfamily C, member 3 | 0.011 | ||
| RBP5 | retinol binding protein 5, cellular | 0.011 | ||
| CD226 | CD226 molecule | 0.011 | ||
| CST1 | cystatin SN | 0.011 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.011 | ||
| GABRP | gamma-aminobutyric acid (GABA) A receptor, pi | 0.011 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.011 | ||
| CTSG | cathepsin G | 0.011 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.011 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.011 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.011 | ||
| IRF5 | interferon regulatory factor 5 | 0.011 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.011 | ||
| LILRA5 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 0.011 | ||
| DUOX2 | dual oxidase 2 | 0.011 | ||
| ACP5 | acid phosphatase 5, tartrate resistant | 0.011 | ||
| PDZK1IP1 | PDZK1 interacting protein 1 | 0.011 | ||
| CHRNA1 | cholinergic receptor, nicotinic, alpha 1 (muscle) | 0.011 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.011 | ||
| LPO | lactoperoxidase | 0.011 | ||
| KCNMB1 | potassium large conductance calcium-activated channel, subfamily M, beta member 1 | 0.011 | ||
| PLAT | plasminogen activator, tissue | 0.011 | ||
| EMP1 | epithelial membrane protein 1 | 0.011 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.011 | ||
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.011 | ||
| SLC22A13 | solute carrier family 22 (organic anion transporter), member 13 | 0.011 | ||
| CD28 | CD28 molecule | 0.011 | ||
| C20orf114 | chromosome 20 open reading frame 114 | 0.011 | ||
| CRMP1 | collapsin response mediator protein 1 | 0.011 | ||
| GPR132 | G protein-coupled receptor 132 | 0.011 | ||
| AIM2 | absent in melanoma 2 | 0.011 | ||
| ABI3BP | ABI family, member 3 (NESH) binding protein | 0.011 | ||
| DEFA6 | defensin, alpha 6, Paneth cell-specific | 0.011 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.011 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.011 | ||
| DYNLT3 | dynein, light chain, Tctex-type 3 | 0.011 | ||
| STRA6 | stimulated by retinoic acid gene 6 homolog (mouse) | 0.011 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.011 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.011 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.011 | ||
| SLC1A7 | solute carrier family 1 (glutamate transporter), member 7 | 0.011 | ||
| PTGES | prostaglandin E synthase | 0.011 | ||
| S100A5 | S100 calcium binding protein A5 | 0.011 | ||
| HABP2 | hyaluronan binding protein 2 | 0.011 | ||
| SSTR3 | somatostatin receptor 3 | 0.011 | ||
| PPP6C | protein phosphatase 6, catalytic subunit | 0.011 | ||
| SIGLEC10 | sialic acid binding Ig-like lectin 10 | 0.011 | ||
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.011 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.010 | ||
| LY9 | lymphocyte antigen 9 | 0.010 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.010 | ||
| C4orf7 | chromosome 4 open reading frame 7 | 0.010 | ||
| CD180 | CD180 molecule | 0.010 | ||
| TPSG1 | tryptase gamma 1 | 0.010 | ||
| KIR2DL2 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 and killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 | 0.010 | ||
| PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.010 | ||
| CYTH4 | cytohesin 4 | 0.010 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.010 | ||
| EGR2 | early growth response 2 | 0.010 | ||
| PARVG | parvin, gamma | 0.010 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.010 | ||
| APLNR | apelin receptor | 0.010 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.010 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.010 | ||
| CYP27B1 | cytochrome P450, family 27, subfamily B, polypeptide 1 | 0.010 | ||
| TBX19 | T-box 19 | 0.010 | ||
| OSCAR | osteoclast associated, immunoglobulin-like receptor | 0.010 | ||
| BATF3 | basic leucine zipper transcription factor, ATF-like 3 | 0.010 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.010 | ||
| NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) | 0.010 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.010 | ||
| C10orf99 | chromosome 10 open reading frame 99 | 0.010 | ||
| REG1A | regenerating islet-derived 1 alpha | 0.010 |